SARS News and Research

RSS

Role of CRISPR-Cas12a visual biosensor in detection of SARS-CoV-2

A new study aimed to develop a novel CRISPR-Cas12a powered visual biosensor for the detection of SARS-CoV-2.

13 Oct 2021

New method to diagnose anosmia

In a recent study, researchers discuss a new method of tracking the Nav1.7 channel to reduce the reliance on more invasive diagnostic measures.

13 Oct 2021

New high-throughput assay could help development of anti-COVID-19 drugs

In a recent study, researchers develop a new high-throughput assay that allows for rapid screening of potential inhibitors.

13 Oct 2021

Genetic characteristics of possible new Alphacoronavirus species found in Bats

A recent study identifies a novel Alphacoronavirus isolated from bats, in Korea, in 2020.

13 Oct 2021

COVID-19 vaccination induces transient increase in cellular and antibody responses to S1 antigenic sequence

Scientists have characterized T-cell, B-cell, and IgG responses to S antigenic sequences to evaluate vaccine effectiveness.

13 Oct 2021

Fraunhofer researchers investigate how viruses can be efficiently eliminated from indoor air

How can viruses be effectively eliminated from indoor air? This question is now becoming more important as fall approaches. Efficient indoor air purification is essential, especially in schools.

13 Oct 2021

Comparing lateral flow testing with RT-PCR to detect SARS-CoV-2

Lateral flow devices (LFDs) are point-of-care tests that require significantly more time to develop than RT-PCR assays but can be used locally with minimal to no training, some of which can provide results in as little as 30 minutes. However, there have been some worries about the sensitivity of such kits. As a result, researchers from Micropathology Ltd have been comparing the two methods.

12 Oct 2021

How long does natural immunity produced by SARS-CoV-2 infection last?

A new study posted to the bioRxiv* preprint server followed the adaptive immune response in convalescent patients from Swedish and Italian cohorts—which had earlier shown long-lasting adaptive immune responses to the G614 strain—for 15 months. Here, specific antibody levels and neutralizing antibody titers were tested against variants of concern (VOCs).

12 Oct 2021

Scientists develop an extremely potent siRNA with broad activity against SARS-CoVs

Researchers in Germany have developed a promising approach to suppressing the viral replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

12 Oct 2021

New eco-friendly solution to fight against malaria

Mosquitoes can and do feed on HMBPP-supplemented beetroot juice. This is the findings of a study at Stockholm University.

12 Oct 2021

Research finds county-level differences in COVID outcomes based on college policy

A recent study panalyzes the number of SARS-CoV-2 infections and related deaths in education campuses.

12 Oct 2021

Rapid measurement of SARS-CoV-2 spike T-cells

Researchers measure SARS-CoV-2 T-cell responses in individuals vaccinated or in those who developed immunity from a prior natural infection.

12 Oct 2021

A survey on computational methods in discovering protein inhibitors of SARS-CoV-2

Researchers review diverse computational methods for drug/inhibitor design and enzymes as potential targets for inhibitors to treat coronaviruses diseases.

12 Oct 2021

New modeling highlights the role of socio-economic status in Covid-19 transmission in Kenya

Combining data on antibody prevalence, PCR test results, genomic surveillance and population mobility from smartphones has allowed infectious disease modelers to explain the evolution of the first three Covid-19 waves that have affected Kenya since the start of the pandemic.

12 Oct 2021

A mucoadhesive polymer with anti-SARS-COV-2 activity in vitro and in vivo

The team has evaluated a low molecular weight chitosan derivative as a candidate preventing the viral entry into mammalian nasal epithelial cells to limit the spread of COVID-19.

12 Oct 2021

Vaccinated children induced significantly higher antibody titers than naturally SARS-CoV-2 infected children

A recent preprint discusses the antibody response to the nucleic acid vaccines against SARS-CoV-2 when administered to children aged 7-11 years.

12 Oct 2021

Novel vaccine demonstrates high efficacy for prevention of COVID-19

The clinical trial studied the efficacy of Novavax’s COVID-19 vaccine, NVX-CoV2373, and found it highly effective in preventing mild, moderate, and severe COVID-19 after full vaccination.

12 Oct 2021

COVID-19 vaccine effectiveness in New York state

A new preprint assessed vaccine effectiveness in 8.8 million people in New York six months after vaccination.

12 Oct 2021

Development of disinfection process based on ozone for highly efficient inactivation of SARS-CoV-2

This study aimed to evaluate the ozone capacity generated within a newly developed disinfection chamber to eradicate SARS-CoV-2 from porous materials and non-porous materials like glass.

12 Oct 2021

Research reveals components of Sinbis virus ribonucleoproteins

To address this gap in research regarding the understanding of post-replicative alphavirus RNPs, scientists have created a novel proteome-wide approach known as viral RNA interactome capture (vRIC). This study is available in the bioRxiv* preprint server while awaiting peer review.

11 Oct 2021

SARS News and Research

Role of CRISPR-Cas12a visual biosensor in detection of SARS-CoV-2

New method to diagnose anosmia

New high-throughput assay could help development of anti-COVID-19 drugs

Genetic characteristics of possible new Alphacoronavirus species found in Bats

COVID-19 vaccination induces transient increase in cellular and antibody responses to S1 antigenic sequence

Fraunhofer researchers investigate how viruses can be efficiently eliminated from indoor air

Comparing lateral flow testing with RT-PCR to detect SARS-CoV-2

How long does natural immunity produced by SARS-CoV-2 infection last?

Scientists develop an extremely potent siRNA with broad activity against SARS-CoVs

New eco-friendly solution to fight against malaria

Research finds county-level differences in COVID outcomes based on college policy

Rapid measurement of SARS-CoV-2 spike T-cells

A survey on computational methods in discovering protein inhibitors of SARS-CoV-2

New modeling highlights the role of socio-economic status in Covid-19 transmission in Kenya

A mucoadhesive polymer with anti-SARS-COV-2 activity in vitro and in vivo

Vaccinated children induced significantly higher antibody titers than naturally SARS-CoV-2 infected children

Novel vaccine demonstrates high efficacy for prevention of COVID-19

COVID-19 vaccine effectiveness in New York state

Development of disinfection process based on ozone for highly efficient inactivation of SARS-CoV-2

Research reveals components of Sinbis virus ribonucleoproteins

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News